Leukemia

Welcome to Leukemia

Leading journal covering all aspects of the research and treatment of leukemia and allied diseases.

Featured

Real-world analysis of teclistamab in 123 RRMM patients from Germany

C. Riedhammer
F. Bassermann
L. Rasche
ArticleOpen Access20 Jan 2024
Prognostic impact of CEBPA mutational subgroups in adult AML

Julia-Annabell Georgi
Sebastian Stasik
Christian Thiede
ArticleOpen Access16 Jan 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

Luise Fischer
Nora Grieb
Maximilian Merz
ArticleOpen Access06 Jan 2024
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

Elias K. Mai
Thomas Hielscher
Hartmut Goldschmidt
ArticleOpen Access07 Dec 2023

Current issue

Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol

Maria Agustina Perusini
Claire Andrews
Hassan Sibai
Correspondence02 Mar 2024
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma

Lin-Rui Gao
Xin Li
Shu-Nan Qi
Correspondence19 Mar 2024
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

Marie Sébert
Lucie Freiman
Matthieu Duchmann
Correspondence17 Feb 2024
The evolution of preclinical models for myelodysplastic neoplasms

Alain Mina
Steven Pavletic
Peter D. Aplan
Review ArticleOpen Access23 Feb 2024
Leukemogenesis occurs in a microenvironment enriched by extracellular microvesicles/exosomes: recent discoveries and questions to be answered

Mariusz Z. Ratajczak
Janina Ratajczak
Review ArticleOpen Access22 Feb 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

Donal P. McLornan
Tomasz Czerw
Deepti H. Radia
Review Article12 Mar 2024

Contents

View all issues

Announcements

Classification and nomenclature of hematologic diseases

LATEST COLLECTION: The World Health Organization (WHO) Classification of Tumours provides a definitive classification of all tumours, worldwide. This collection includes an overview of the classification of myeloid and histiocytic/dendritic neoplasms and the classification of lymphoid neoplasms.
Emerging Leaders in Leukemia

This Emerging Leaders collection acknowledges and showcases the latest research from groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers.
Get your manuscript ready for journal editors

Follow our checklist to avoid common mistakes to help get your manuscript to journal editors faster. We also offer a FREE language check from our partner AJE.

Browse articles

8-Cl-Ado and 8-NH₂-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia

Jiamin Guo
Ralf Buettner
Steven T. Rosen
ArticleOpen Access20 Apr 2024
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia

Shinju Iyoda
Kenichi Yoshida
Hidemasa Matsuo
Letter18 Apr 2024
Measurable residual disease (MRD)-testing in haematological and solid cancers

Junren Chen
Robert Peter Gale
Wei Zhang
PerspectiveOpen Access18 Apr 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Christopher Maximilian Arends
Klara Kopp
Frederik Damm
ArticleOpen Access18 Apr 2024
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DR^low/neg monocytes in lower-risk myelodysplastic neoplasms

Susann Winter
Marie Schneider
Shahram Kordasti
LetterOpen Access17 Apr 2024
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation

Wenyi Lu
Hairong Lyu
Mingfeng Zhao
LetterOpen Access17 Apr 2024
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia

Nandita Noronha
Chantal Durette
Gregory Ehx
ArticleOpen Access16 Apr 2024
Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations

Nikola Curik
Adam Laznicka
Katerina Machova Polakova
LetterOpen Access13 Apr 2024
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression

Shinichiro Matsui
Chihiro Ri
Tomoya Muto
ArticleOpen Access12 Apr 2024

Welcome to Leukemia

Featured

Real-world analysis of teclistamab in 123 RRMM patients from Germany

Prognostic impact of CEBPA mutational subgroups in adult AML

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

Current issue

Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol

Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

The evolution of preclinical models for myelodysplastic neoplasms

Leukemogenesis occurs in a microenvironment enriched by extracellular microvesicles/exosomes: recent discoveries and questions to be answered

Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

Announcements

Classification and nomenclature of hematologic diseases

Emerging Leaders in Leukemia

Get your manuscript ready for journal editors

Browse articles

8-Cl-Ado and 8-NH₂-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia

Measurable residual disease (MRD)-testing in haematological and solid cancers

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DR^low/neg monocytes in lower-risk myelodysplastic neoplasms

Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation

Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia

Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations

Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression

Trending - Altmetric

Search

Quick links

Featured

Announcements

Advertisement

Trending - Altmetric

An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms

Search

Quick links